chemokine receptor antagonists (Celltech)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namechemokine receptor antagonists (Celltech)
Drug Alias NameCCR3 antagonists (Celltech)G-protein coupled receptor antagonists (Celltech)GPCR antagonists (Celltech)CXCR2 antagonists (Celltech)cytokine inhibitors (Celltech/Schering Plough)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionC-X-C motif chemokine receptor 2 antagonistsC-C chemokine receptor type 3 antagonists
TargetsC-C chemokine receptor type 3C-X-C motif chemokine receptor 2
Therapy Area/IndicationsInflammationHypersensitivityAsthma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesUcb Celltech
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUcb CelltechSchering-Plough Corp
Active IndicationsN/A
Inactive IndicationsInflammationHypersensitivityAsthma

Other Information

ATC CodeN/A
Related LinksN/A